Please assess the completion status of the following clinical trial:

Trial Title: Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with stable coronary artery disease (CAD) or acute coronary syndromes (ACS) following percutaneous coronary intervention (PCI)~Exclusion Criteria:~* abnormal platelet count in patients,~* severe liver disorders,~* current gastrointestinal disorders,~* current infections,~* congestive heart failure,~* known bleeding disorders,~* treatment with bivalirudin or glycoprotein IIb/IIIa antagonists within the last 7 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- aspirin, clopidogrel (Type: EXPERIMENTAL): If the treatment with aspirin and/or clopidogrel is insufficient (platelet function testing) the dose was increased or the drug was changed (clopidogrel to ticlopidine or prasugrel)

Based on this trial design, predict the completion outcome and termination type (if applicable).